Cyclobenzaprine Hydrochloride Tablet
Product Images NDC 0615-8665

2 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0615-8665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine 8665 1)

Image (Cyclobenzaprine 8665 1)
Chemical structure of Cyclobenzaprine Hydrochloride, showing a three-ring system and the molecular formula including the hydrochloride component.*
FDA Label Image

Principal Display Panel (Cyclobenzaprine 8665 2)

Principal Display Panel (Cyclobenzaprine 8665 2)
Cyclobenzaprine Hydrochloride Tablets USP 10 mg label by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes a barcode, lot number 8665, quantity 30 tablets, and storage instructions. It is for institutional use only and includes multiple smaller barcode labels for individual tablets or packaging units. Manufacturer listed as Graviti for Rising and packaging by Vangard, Glasgow, KY 42141.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.